Fit couple walking together on a scenic outdoor path on a bright morning

What Are Peptides?

A peptide is a short chain of amino acids, typically between 2 and 50, linked by peptide bonds. If proteins are paragraphs, peptides are individual words: smaller, more specific, and more targeted. Your body already produces thousands of them. Insulin is a peptide. Oxytocin is a peptide. The growth hormone signals your pituitary sends during deep sleep are peptides.

Unlike a drug that forces a response, most therapeutic peptides work by amplifying signals your body already uses. When you cut your finger, peptides signal repair cells to migrate to the wound. Peptide therapy provides more of those specific signals to encourage a biological process that is already happening, just not as robustly as you might want.[5] For the full primer, read our beginner's guide to peptides.

FDA-Approved

GLP-1 Agonists

Semaglutide, tirzepatide. Large-scale clinical trials, thousands of patients, years of data.

Clinical Data

GH Secretagogues

CJC-1295, Ipamorelin. Human clinical trials exist. Favorable safety profiles but not FDA-approved for this use.

Preclinical + Case Data

Healing Peptides

BPC-157, TB-500. Hundreds of animal studies, growing human case reports. No large-scale human RCTs.

Early Research

Cognitive Peptides

Selank, Semax. Neuroprotective research mostly from Russian studies. Limited Western clinical data.

This page is for educational purposes only and is not medical advice. Peptide therapy should only be considered under supervision of a qualified healthcare provider. Nothing here is a recommendation to use, purchase, or self-administer any compound.

GLP-1 Medications

GLP-1 receptor agonists are the peptides that have entered the mainstream, largely through Ozempic, Wegovy, and Mounjaro. These are FDA-approved medications backed by extensive clinical trial data. GLP-1 is a hormone your gut naturally releases after eating. It signals your pancreas to release insulin (only when blood sugar is elevated), slows gastric emptying, and acts on appetite centers in the brain to reduce hunger. For a detailed timeline of what to expect, see our week-by-week GLP-1 guide.

Woman preparing a protein-rich meal with fresh vegetables in a modern kitchen

GLP-1 Clinical Trial Results

TrialMedicationKey Finding
STEP 1Semaglutide (Wegovy)15-17% average body weight loss over 68 weeks
SURMOUNT-1Tirzepatide (Mounjaro)Up to 22.5% weight loss at highest dose
SELECTSemaglutide20% reduction in major cardiovascular events in obesity without diabetes

What to Expect

TimelineWhat Happens
Weeks 1-4Appetite reduction is first effect. Food becomes less interesting. 2-5 lbs loss, partly water.
Weeks 4-12Weight loss accelerates with dose titration. Smaller portions feel satisfying. Cravings decrease.
Months 3-6Metabolic improvements on bloodwork: HbA1c, fasting glucose, triglycerides. 10-15% weight loss.
Months 6-12+Weight loss slows approaching new equilibrium. Focus shifts to maintenance and body composition.

Side Effects

Side effects are common during dose titration but usually transient. Being prepared makes a real difference.

Nausea

Smaller meals, avoid fatty foods, stay hydrated. Usually fades after 2-3 weeks.

Read the guide →

Constipation

Fiber, extra water (more than you think), magnesium. Slower gastric emptying = slower transit.

Read the guide →

Low Appetite

Prioritize protein targets even when not hungry. Track intake to avoid undereating.

Read the guide →

Fatigue

Often related to undereating or dehydration, not the drug itself. Track intake first.

Read the guide →

The Muscle Preservation Problem

Roughly 25-40% of weight lost on GLP-1 medications is lean mass, including muscle.[4] That is not unique to these drugs, but it matters, especially for people over 40 already dealing with sarcopenia. The solution: resistance training (2-3 sessions per week minimum) and high protein intake (1.0-1.2g per pound of lean body mass, spread across 3-4 meals). The medication handles the caloric side. You handle the stimulus and substrate for keeping muscle.

See the training guide for programming principles and the protein targets guide for per-meal breakdowns.

Recovery Peptides

Recovery peptides occupy more ambiguous territory than GLP-1s. These are compounds with genuinely interesting research, some with decades of published data, but without the large-scale human trials that earn FDA approval. The evidence ranges from extensive (BPC-157 has hundreds of studies) to moderate (TB-500 has solid preclinical and some clinical data) to emerging.[6] For a deep dive, read our recovery peptides article.

Man doing a physical therapy exercise with a resistance band, guided by a therapist

Preclinical + Case Data

BPC-157

Body Protection Compound

15-amino-acid fragment from human gastric juice. Promotes angiogenesis, upregulates VEGF and FGF receptors, accelerates collagen deposition. Hundreds of animal studies across tendon, ligament, muscle, bone, and gut models.[5]

Use cases: Tendon/ligament injuries, gut healing (IBS, leaky gut), muscle tears, post-surgical recovery.

Clinical + Preclinical

TB-500

Thymosin Beta-4

43-amino-acid peptide from the thymus gland. Promotes cell migration, upregulates actin, reduces pro-inflammatory cytokines, promotes tissue remodeling without excessive scarring.[7] Clinical trials exist for corneal and cardiac repair.

Use cases: Soft tissue injuries, wound healing, inflammatory conditions. Often combined with BPC-157 ("Wolverine Stack").

Clinical Data

CJC-1295 + Ipamorelin

GH Secretagogue Stack

CJC-1295 is modified GHRH. Ipamorelin mimics ghrelin selectively. Together they produce pulsatile GH release mimicking natural sleep patterns, preserving the feedback loop unlike exogenous GH.[8]

Use cases: Training recovery, sleep quality, body composition in age-related GH decline, fat metabolism.

The "Wolverine Stack" (BPC-157 + TB-500) addresses different healing pathways: BPC-157 promotes vascular repair and gut-mediated healing, while TB-500 focuses on cell migration and inflammation control. The combination makes mechanistic sense, but "makes sense" and "proven in large-scale trials" are different things. Work with a clinician who understands these compounds.

Safety, Sourcing & Monitoring

The peptide space has a sourcing problem. The quality of what you put into your body depends entirely on where it comes from, how it was manufactured, and whether anyone verified it before it reached you.

Patient having a conversation with his doctor in a bright modern medical office

The Sourcing Hierarchy

SourceQualityRisk Level
FDA-approved pharmacyHighest — cGMP manufacturing, batch-tested for purity, potency, sterilityLowest
503B compounding pharmacyGood — FDA-overseen outsourcing facilities, physician order requiredLow-Moderate
503A compounding pharmacyVariable — less FDA oversight than 503B, quality depends on the pharmacyModerate
Research chemical supplierUnknown — "for research only" label, no pharma standards, purity 50-99%High

Green Flags

  • Third-party COA available for each batch
  • HPLC purity testing showing 98%+
  • Endotoxin and sterility testing documented
  • Proper cold-chain shipping
  • Physician referral or prescription required

Red Flags

  • No COA or generic-looking certificates
  • Pricing well below market rate
  • Claims oral peptides match injection bioavailability
  • No cold-chain shipping
  • Marketing that sounds like supplement hype

Monitoring and Bloodwork

If you use peptides, you need to monitor. "I feel fine" is not a monitoring strategy. Baseline bloodwork before starting, follow-up at 6-8 weeks, then every 3-6 months on protocol.

ProtocolKey Markers to Track
GLP-1 medicationsHbA1c, fasting glucose/insulin, lipids, liver enzymes, kidney function, thyroid, amylase/lipase, body comp
GH secretagoguesIGF-1 (primary), fasting glucose/insulin, HbA1c, pituitary panel
Healing peptides (BPC-157, TB-500)CBC, CMP, inflammatory markers (CRP, ESR). Add GI panel if using for gut healing
Peptides should only be used under the guidance of a qualified healthcare provider. Self-administration without medical oversight increases your risk of contaminated products, incorrect dosing, drug interactions, and unmonitored side effects. If your provider is not familiar with peptide therapy, find one who is.

Who Should Consider Peptides

Peptides are tools. They work best when applied to the right problem at the right time. The biggest mistake is reaching for a peptide solution before building the foundation that makes it effective.

May Benefit

  • Soft tissue injury plateaued despite PT and rehab
  • Chronic GI issues unresolved by dietary changes
  • Over 35 with measurable decline in recovery and body comp despite training
  • Meet clinical criteria for GLP-1, confirmed by your physician
  • Using peptides to add to a solid foundation, not replace it

Should Pause

  • Have not optimized sleep, nutrition, and training first
  • Looking for a shortcut (peptides are not shortcuts)
  • No physician willing to supervise and monitor bloodwork
  • Pregnant, nursing, or trying to conceive
  • Active cancer or uncontrolled autoimmune condition

The Optimization Hierarchy

Think of it as a pyramid. The base is fundamentals: sleep, nutrition, training, stress management. These account for 80-90% of your outcomes. The next layer is testing and monitoring: bloodwork, body composition tracking, performance metrics. Peptides sit near the top. They can provide a meaningful edge, but only if the layers beneath them are solid. Nobody needs a GH secretagogue more than they need seven hours of consistent sleep. Build the pyramid from the bottom up.

Start with the recovery guide and the hormones guide to build the foundation. Peptides are most effective when everything else is already working.

Go Deeper

This guide covers the landscape. These articles go deep on specific topics:

References

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002.
  2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216.
  3. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232.
  4. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes Obes Metab. 2022;24(8):1553-1564.
  5. Sikiric P, et al. Pentadecapeptide BPC 157 and its role in cytoprotection and stress coping. World J Gastroenterol. 2020;26(42):6567-6587.
  6. Seiwerth S, et al. BPC 157 and standard angiogenic growth factors: healing lessons. Curr Pharm Des. 2018;24(18):1972-1989.
  7. Goldstein AL, et al. Thymosin beta-4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
  8. Teichman SL, et al. Prolonged stimulation of GH and IGF-I by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805.

Explore the Peptide Database

Browse detailed compound profiles with linked research, dosing protocols, and mechanism-of-action breakdowns.